Inhibition of Platelet-Derived Growth Factor Promotes Pericyte Loss and Angiogenesis in Ischemic Retinopathy
- 1 April 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 164 (4) , 1263-1273
- https://doi.org/10.1016/s0002-9440(10)63214-2
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Pharmacology of imatinib (STI571)European Journal Of Cancer, 2002
- Glivec (STI571, imatinib), a rationally developed, targeted anticancer drugNature Reviews Drug Discovery, 2002
- PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritisKidney International, 2001
- Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survivalThe FASEB Journal, 2001
- Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathyExperimental and Clinical Endocrinology & Diabetes, 2000
- Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient MiceScience, 1997
- Increased production of PDGF by angiotensin and high glucose in human vascular endotheliumLife Sciences, 1996
- Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblastsThe Journal of cell biology, 1993
- Epidemiology of Proliferative Diabetic RetinopathyDiabetes Care, 1992
- Role of platelet‐derived growth factor in wound healingJournal of Cellular Biochemistry, 1991